scholarly journals Analysis of the Change in Seropositive Rate of Epstein-Barr Virus in Koreans: A Single-Center Study

2020 ◽  
Vol 27 (2) ◽  
pp. 117
Author(s):  
Su Kyung Kim ◽  
Joon-Sik Choi ◽  
Dongsub Kim ◽  
Cheol-In Kang ◽  
Doo Ryeon Chung ◽  
...  
Keyword(s):  
Epstein Barr Virus ◽  
Single Center ◽  
Seropositive Rate ◽  
Barr Virus ◽  
Single Center Study ◽  
Epstein Barr ◽  
Center Study

scholarly journals Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Yun Xie ◽  
Song Cao ◽  
Hui Dong ◽  
Hui Lv ◽  
Xiaolei Teng ◽  
...  
Keyword(s):  
Epstein Barr Virus ◽  
Mortality Rates ◽  
Virus Reactivation ◽  
Barr Virus ◽  
Ebv Reactivation ◽  
Imaging Characteristics ◽  
Single Center Study ◽  
Significant Difference ◽  
Epstein Barr ◽  
Epstein Barr Virus Reactivation

Abstract Background Our goal is to further elucidate the clinical condition and prognosis of patients with severe acute COVID-19 with EBV reactivation. Method This is a retrospective single-center study of COVID-19 patients admitted to the intensive care unit of Wuhan No. 3 Hospital (January 31 to March 27, 2020). According to whether Epstein-Barr virus reactivation was detected, the patients were divided into an EBV group and a Non-EBV group. Baseline data were collected including epidemiological, larithmics, clinical and imaging characteristics, and laboratory examination data. Results Of the 128 patients with COVID-19, 17 (13.3%) were infected with Epstein-Barr virus reactivation. In the symptoms,the rate of tachypnoea in the EBV group was apparently higher than that in the Non-EBV group. In lab tests, the lymphocyte and albumin of EBV group decreased more significantly than Non-EBV group, and the D-dimer and serum calcium of EBV group was higher than Non-EBV group. Regarding the infection index, CRP of EBV group was apparently above the Non-EBV group, and no significant difference was found in procalcitonin of the two groups. The incidence of respiratory failure, ARDS, and hypoproteinaemia of EBV group had more incidence than Non-EBV group. The 28-day and 14-day mortality rates of EBV group was significantly higher than that of Non-EBV group. Conclusions In the COVID-19 patients, patients with EBV reactivation had higher 28-day and 14-day mortality rates and received more immuno-supportive treatment than patients of Non-EBV group.

SINGLE-CENTER ANALYSIS OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) OUTCOMES WITH EPSTEIN BARR VIRUS (EBV) ASSESSMENTS

2019 ◽  
Vol 37 ◽  
pp. 530-530
Author(s):  
M.O. Kamal ◽  
J. Moyers ◽  
L. Liu ◽  
M. Kim ◽  
H. Mo ◽  
...  
Keyword(s):  
Lymphoproliferative Disorder ◽  
Epstein Barr Virus ◽  
Single Center ◽  
Post Transplant ◽  
Barr Virus ◽  
Epstein Barr

Epstein-Barr virus-associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center

2013 ◽  
Vol 27 (4) ◽  
pp. E462-E468 ◽  
Author(s):  
Chieh Suai Tan ◽  
Hwai-Liang Loh ◽  
Marjorie Wai Yin Foo ◽  
Lina Hui Lin Choong ◽  
Kok Seng Wong ◽  
...  
Keyword(s):  
Smooth Muscle ◽  
Kidney Transplantation ◽  
Epstein Barr Virus ◽  
Single Center ◽  
Barr Virus ◽  
Smooth Muscle Tumors ◽  
Epstein Barr
Sign in / Sign up

Export Citation Format

Share Document